14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 115 days ( -1.31 % )
Last Price $8.50 0 %
High/ Low $8.50 - $8.50 0%
Chg 7 Days N/A $8.50 $8.50
Chg 30 Days N/A $8.50 $8.50
Chg 12 mos 2,196.06 % $0.370 $8.50
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 115.34 % Width: 91.35 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $14.91 - $28.53 75.42 % - 235.66 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Aug 16, 2023 - 91 days
Long MA avg 12 mos Buy Jul 11, 2023 - 117 days
Short/Long MA avg 12 mos Buy Jan 31, 2023 - 227 days
Pivot Short Sell Dec 21, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Liminal Biosciences Inc.

Liminal Biosciences. Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives ... LMNL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT